Shanghai Junshi Biosciences Co Ltd
SSE:688180
Relative Value
The Relative Value of one Shanghai Junshi Biosciences Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 34.65 CNY, Shanghai Junshi Biosciences Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shanghai Junshi Biosciences Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Junshi Biosciences Co Ltd
SSE:688180
|
35.6B CNY | 13.9 | -36.4 | -35.2 | -35.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 746 422.5 | -160 391.7 | -165 649.1 | -163 758.9 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.8B USD | 6.7 | 169.8 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
185.3B USD | 5.2 | 26.5 | 18.9 | 18.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
177.3B USD | 6.1 | 21.9 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120B USD | 10.2 | 32.6 | 24 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 087.6 | -532.7 | -682 | -663.8 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.5 | 17.6 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
86.7B AUD | 3.8 | 19.7 | 9.1 | 11.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.8B EUR | 14.3 | 33.6 | 68 | 69.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.7 | -78.2 | -70.5 |